The Foundation of the Consortium of Multiple Sclerosis Centers is committed to operating under the principles of and in compliance with all applicable laws, rules and regulations, including the guidelines and standards set forth by accrediting continuing education providers.
The Foundation of the CMSC agrees:
- To utilize contributed funds for actual and reasonable expenses of the program or initiative specified in the initial request, with addendums to be filed with grantor’s approval should reallocation be necessary;
- To use funds in strict accordance with the budget submitted with the grant request;
- To furnish contributors with reconciliation reports concerning the expenditure of grant funds, supported by appropriate substantiation; and.
- To promptly report any unused grant funds.
Programs or initiatives supported by the Foundation of the CMSC will not promote individual products, directly or indirectly, with any activity focused on educational content being free from commercial influence or bias.
The Foundation of the CMSC is responsible for designing and conducting programs and initiatives. The Foundation of the CMSC will disclose financial or other relationships between financial contributors and will provide this information in writing. Content development will include input from independent professional and/or scientific sources, and will make selection of presenters(s), faculty or advisory panels based on balance and independence.
The Foundation of the CMSC will ensure a meaningful disclosure is made of financial or in-kind support and any significant relationship between the organizers of FCMSC programs or initiatives and donors or contributors (e.g., employee, grant recipient, principal investigator in clinical trial, on speakers’ bureau, owner of significant interest or stock, etc.).
The Foundation of the CMSC agrees to appropriately acknowledge educational or charitable support in program brochures, syllabi and other materials.
Board of Trustees
Michael K. Racke, MD
Dr. Racke is Professor and Chair of the Department of Neurology College of Medicine at Ohio State University. An international leader in neurological sciences, Dr. Racke is a distinguished scholar known for his research in immunology and multiple sclerosis. Dr. Racke serves on many advisory committees and currently is the chair of the Clinical Neuroimmunology and Brain Tumors (CNBT) NIH Study Section.
He has received the prestigious Harry Weaver Neuroscience Scholarship from the National Multiple Sclerosis Society and the Young Investigator in Multiple Sclerosis Award from the American Academy of Neurology Education and Research Foundation.
Board certified in Neurology, Dr. Racke’s clinical and research interests are neuroimmunology and multiple sclerosis, specifically studying disease pathogenesis and developing novel therapies.
Gary R. Cutter, MS, PhD
Dr. Cutter is Professor of Biostatistics in the UAB School of Public Health in the Department of Biostatistics. Dr. Cutter has a major interest in design, analysis and interpretation of clinical trials, epidemiologic studies and evaluation research. Dr. Cutter has over 40 years of experience in coordinating centers, directing numerous centers for national and international clinical trials and cores on program projects and collaborative grants. He is an invited speaker nationally as well as internationally. He is currently directing the coordinating centers of multiple NIH randomized trials: the recently completed trial of Combination Therapy in Multiple Sclerosis (CombiRx) and the Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis Complex and the randomized Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis (PREVeNT trial) all NINDS funded studies. He directs the coordinating center for the NHLBI Chronic Hypertension in Pregnancy (CHAP). He is the PI of the Trial of Thymectomy plus Prednisone versus Prednisone alone in the treatment of non-thymomatous Myasthenia Gravis (MGTx). He is Deputy Director of the Operations Center of the Neurofibromatosis Consortium, which runs multiple studies simultaneously funded by the Department of Defense as well as director of the Data Management Center for the Collaborative Antiviral Study Group, another network designed to run multiple trials within a collaborative organizational structure. He is the Director, Biostatistics/Bioinformatics Resource (BBR) Core Center for Acute Kidney Injury Research, UAB-USC (NIDDK), Director, Center For Aids Research, Biostatistics Core, UAB (NIAID) and Deputy Director, National Center for High Impact Clinical Trials in Rehabilitation Medicine with Dr. Bamman.
He is a member of numerous data and safety monitoring committees for the NIH, Pharmaceutical Companies and foundations as well as advisory committees. He has been active in evaluation and outcome measures, developing the Multiple Sclerosis Functional Composite, a disability measure widely used in MS, serves on the International Clinical Trials Committee of the National MS Society and International MS Societies as well as being on the editorial board of the journal MS and writes a column Statistics for the Neurologist in Practice for Neurology for clinical practice as a contributing editor. He is an Associate Editor of Alzheimer’s Disease Translational Research. He is also a statistical consultant for Journal of the American Society of Nephrology (JASN). He has worked with NINDS on the Common Data Elements project as a participant in the overall advisory committee and on several disease specific development efforts. He has been the PI of an NINDS T32 training grant and co-director of an NHLBI T32 training grant. He is a mentor on numerous K awards from across campus, PhD and master’s students and teaches in various national and international short courses.
Patricia Bobryk, MHS, PT, MSCS, ATP
Patty Bobryk is a graduate of the physical therapy program at Wayne State University in Detroit, Michigan. She obtained her master’s degree in neuro-dysfunction from the University of Florida in 1991. Since that time she has worked nearly exclusively with individuals with multiple sclerosis for Orlando Health in collaboration with the MS Comprehensive Care Center of Central Florida. She is credentialed as a MS Certified Specialist and has earned her certification as an Assistive Technology Practitioner.
Patty has been active in the Mid Florida MS Society’s Chapter Advisory Committee and has provided educational seminars for professionals and patients nationwide on rehabilitation for individuals with multiple sclerosis. She served as the Chair of the International Organization of Multiple Sclerosis Rehabilitation Therapists since 2008.
Scott Newsome, DO, MSCS
Dr. Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica, and stiff person syndrome. Dr. Newsome works within the division of Neuroimmunology and Neuroinfectious diseases at Johns Hopkins Hospital. He joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis centers after completing fellowship and he is currently the director of the Johns Hopkins Neurology Outpatient Services and the Neurology Infusion Center.
Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine and graduated with honors. He then completed his internship in internal medicine and residency in neurology at Albany Medical Center. During Dr. Newsome’s neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award and later was chosen to be chief resident. He subsequently went on to complete a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship from the National Multiple Sclerosis Society.
Dr. Newsome’s main research focuses on the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis. These tools may improve the precision of disability measurements in multiple sclerosis and other central nervous system disorders. Currently, Dr. Newsome is involved in several clinical trials for multiple sclerosis, transverse myelitis, and neuromyelitis optica. He is also serving as chair for the Consensus Conference Committee of the Consortium of MS Centers and is an advisor for the National Multiple Sclerosis Society Clinical Advisory Committee.
Anne Cross, MD
Senior CMSC Member-at-Large
Anne H Cross, MD, is Professor in the Department of Neurology at Washington University School of Medicine in St Louis, MO. She received her medical degree from the University of Alabama School of Medicine and completed her neurology residency training at George Washington University, serving as Chief Resident in her final year. Following 6 years of fellowship training in the Neuroimmunology Branch at the National Institutes of Health, Saint Jude Children’s Research Hospital, and Albert Einstein College of Medicine, Dr Cross was awarded the Harry Weaver Neuroscience Scholar Award from the National Multiple Sclerosis Society. Her research interests include understanding the mechanisms involved in pathogenesis of inflammation and demyelination in the central nervous system (brain and spinal cord). Dr Cross has authored or coauthored several peer-reviewed journal articles that have been published in Archives of Neurology, American Journal of Pathology, and Journal of Leukocyte Biology, amongst others. She is a member of the American Academy of Neurology, International Society of Neuroimmunology, Central Society for Neurologic Research, and American Neurological Association.